Publications
Publications
Show Results For
-
All HBS Web
(118,828)
- Faculty Publications (2,635)
Finance
→
Page 1 of
2,635
Results
→
- January 2021
- Case
mPharma (A)
By: Rembrand Koning, John D. Macomber, Pippa Tubman Armerding and Wale Lawal
mPharma pioneered electronic prescriptions in Ghana, and aimed to increase drug affordability and accessibility in Africa, but the company remained unprofitable. Following investor concerns about mPharma's business, CEO Gregory Rockson considered alternative business...
View Details
Keywords:
Strategy;
Entrepreneurship;
Acquisition;
Health;
Health Industry;
Technology Industry;
Ghana
- January 2021
- Supplement
mPharma (B)
By: Rembrand Koning, John D. Macomber, Pippa Tubman Armerding and Wale Lawal
mPharma pioneered electronic prescriptions in Ghana, and aimed to increase drug affordability and accessibility in Africa, but the company remained unprofitable. Following investor concerns about mPharma's business, CEO Gregory Rockson considered alternative business...
View Details
- January 2021
- Case
Love It or List It: An Aging Asset on Sixth Ave
By: Charles F. Wu, Moe Bakri, Mimi DiSipio, Clay Macfarlane, Sam Rashin and Baruch Shemtov
Keywords:
Real Estate
- January 2021
- Teaching Note
Love It or List It: An Aging Asset on Sixth Ave
By: Charles F. Wu and Sean Bracken
- January 2021
- Article
Using Models to Persuade
By: Joshua Schwartzstein and Adi Sunderam
We present a framework where "model persuaders" influence receivers’ beliefs by proposing models that organize past data to make predictions. Receivers are assumed to find models more compelling when they better explain the data, fixing receivers’ prior beliefs. Model...
View Details
- December 2020
- Supplement
The Tulsa Massacre and the Call for Reparations
By: Mihir A. Desai and Suzanne Antoniou
How should historic social injustices be addressed? Survivors of the 1921 Tulsa Massacre and their descendants believe they should be addressed through reparations and have consequently continued to push the government of Tulsa to pay reparations for the massacre. In...
View Details
Keywords:
Cost Vs Benefits;
Decision Choices And Conditions;
Decisions;
Judgments;
Race;
Fairness;
Moral Sensibility;
Values And Beliefs;
Corporate Accountability;
Corporate Governance;
Policy;
Governing Rules, Regulations, And Reforms;
Government Legislation;
Government And Politics;
Government Administration;
Lawsuits And Litigation;
Legal Liability;
Leading Change;
Mission And Purpose;
Corporate Social Responsibility And Impact;
Conflict And Resolution;
Conflict Management;
Loss;
Motivation And Incentives;
Perspective;
Prejudice And Bias;
Civil Society Or Community;
Social Issues;
Welfare;
Tulsa;
Oklahoma;
United States
- December 2020
- Case
The Dance of Dharma: On the Difficulty of Being Good
By: Arthur I. Segel and Tyler Richard
- December 2020
- Teaching Note
The Tulsa Massacre and the Call for Reparations
By: Mihir A. Desai and Suzanne Antoniou
How should historic social injustices be addressed? Survivors of the 1921 Tulsa Massacre and their descendants believe they should be addressed through reparations and have consequently continued to push the government of Tulsa to pay reparations for the massacre. In...
View Details
Keywords:
Cost Vs Benefits;
Decision Choices And Conditions;
Decisions;
Judgments;
Race;
Fairness;
Moral Sensibility;
Values And Beliefs;
Corporate Accountability;
Corporate Governance;
Policy;
Governing Rules, Regulations, And Reforms;
Government Legislation;
Government And Politics;
Government Administration;
Lawsuits And Litigation;
Legal Liability;
Leading Change;
Mission And Purpose;
Corporate Social Responsibility And Impact;
Conflict And Resolution;
Conflict Management;
Loss;
Motivation And Incentives;
Perspective;
Prejudice And Bias;
Civil Society Or Community;
Social Issues;
Welfare;
Tulsa;
Oklahoma;
United States
- December 2020
- Case
PG&E and the First Climate Change Bankruptcy
By: Stuart C. Gilson and Sarah L. Abbott
In early 2020, the California-based utility PG&E filed a second amended plan of reorganization. PG&E had filed for Chapter 11 bankruptcy in the face of more than $30 billion of legal claims brought against it for its alleged role in causing California wildfires. The...
View Details
- 2020
- Working Paper
Rate-Amplifying Investor Demand and the Excess Sensitivity of Long-Term Interest Rates
By: Samuel G. Hanson, David O. Lucca and Jonathan H. Wright
Long-term nominal interest rates are known to be highly sensitive to high-frequency (daily or monthly) movements in short-term rates. We find that, since 2000, this high-frequency sensitivity has grown even stronger in U.S. data. By contrast, the association between...
View Details
- December 2020
- Article
Monetary Policy and Global Banking
By: Falk Bräuning and Victoria Ivashina
Global banks use their global balance sheets to respond to local monetary policy. However, sources and uses of funds are often denominated in different currencies. This leads to a foreign exchange (FX) exposure that banks need to hedge. If cross-currency flows are...
View Details
- 2020
- Working Paper
In the Red: Overdrafts, Payday Lending and the Underbanked
The reordering of transactions from “high-to-low” is a controversial bank practice thought to maximize fees paid by low-income customers on overdrawn accounts. We exploit multiple class-action lawsuits resulting in mandatory changes to this practice, coupled with...
View Details
- November 2020
- Teaching Note
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
- November 2020
- Supplement
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage...
View Details
- November 2020
- Case
Amazon and the Concrete Jungle
By: Charles F. Wu, Marie Archibald, Will Begley, Maya Kazamel and Ryan Lee
- November 2020
- Teaching Note
Ver de Verdad: I Can See Clearly Now
By: Nori Gerardo Lietz and Terrence Shu
Teaching Note for HBS Case No. 218-040.
View Details
- November 2020
- Case
The 1,000-Year Plan: Lee Kum Kee and Sustaining a Family Culture
By: Lauren Cohen, Dawn H. Lau and Billy Chan
The Lee family, whose Hong Kong-based Lee Kum Kee company has established itself as a legend within the Chinese and Asian sauce world, sets out to create a daring new vision of what family legacy means. With the family business having been established in 1888, and by...
View Details
- November 2020
- Article
Casting Conference Calls
By: Lauren Cohen, Dong Lou and Christopher J. Malloy
We explore a subtle but important mechanism through which firms can control information flow to the markets. We find that firms that “cast” their conference calls by disproportionately calling on bullish analysts tend to underperform in the future. Firms that call on...
View Details